302 related articles for article (PubMed ID: 28880230)
1. Design, Synthesis, Antimycobacterial Evaluation, and In Silico Studies of 3-(Phenylcarbamoyl)-pyrazine-2-carboxylic Acids.
Semelková L; Janošcová P; Fernandes C; Bouz G; Janďourek O; Konečná K; Paterová P; Navrátilová L; Kuneš J; Doležal M; Zitko J
Molecules; 2017 Sep; 22(9):. PubMed ID: 28880230
[TBL] [Abstract][Full Text] [Related]
2. 3-Substituted N-Benzylpyrazine-2-carboxamide Derivatives: Synthesis, Antimycobacterial and Antibacterial Evaluation.
Semelková L; Janďourek O; Konečná K; Paterová P; Navrátilová L; Trejtnar F; Kubíček V; Kuneš J; Doležal M; Zitko J
Molecules; 2017 Mar; 22(3):. PubMed ID: 28335571
[TBL] [Abstract][Full Text] [Related]
3. Discovery of Novel Thiophene-arylamide Derivatives as DprE1 Inhibitors with Potent Antimycobacterial Activities.
Wang P; Batt SM; Wang B; Fu L; Qin R; Lu Y; Li G; Besra GS; Huang H
J Med Chem; 2021 May; 64(9):6241-6261. PubMed ID: 33852302
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and antimycobacterial activity of pyrazine and quinoxaline derivatives.
Seitz LE; Suling WJ; Reynolds RC
J Med Chem; 2002 Dec; 45(25):5604-6. PubMed ID: 12459027
[TBL] [Abstract][Full Text] [Related]
5. Ureidopyrazine Derivatives: Synthesis and Biological Evaluation as Anti-Infectives and Abiotic Elicitors.
Bouz G; Juhás M; Niklová P; Janďourek O; Paterová P; Janoušek J; Tůmová L; Kovalíková Z; Kastner P; Doležal M; Zitko J
Molecules; 2017 Oct; 22(10):. PubMed ID: 29065539
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antimycobacterial evaluation of N-substituted 5-chloropyrazine-2-carboxamides.
Servusová B; Vobicková J; Paterová P; Kubíček V; Kuneš J; Doležal M; Zitko J
Bioorg Med Chem Lett; 2013 Jun; 23(12):3589-91. PubMed ID: 23659859
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of Novel Pyrazinamide Derivatives Based on 3-Chloropyrazine-2-carboxamide and Their Antimicrobial Evaluation.
Jandourek O; Tauchman M; Paterova P; Konecna K; Navratilova L; Kubicek V; Holas O; Zitko J; Dolezal M
Molecules; 2017 Feb; 22(2):. PubMed ID: 28157178
[TBL] [Abstract][Full Text] [Related]
8. In vitro antibacterial and antifungal activity of salicylanilide pyrazine-2-carboxylates.
Krátký M; Vinšová J; Buchta V
Med Chem; 2012 Jul; 8(4):732-41. PubMed ID: 22548336
[TBL] [Abstract][Full Text] [Related]
9. Virtual Screening of Small Molecular Inhibitors against DprE1.
Zhang G; Guo S; Cui H; Qi J
Molecules; 2018 Feb; 23(3):. PubMed ID: 29495447
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and antimycobacterial evaluation of substituted pyrazinecarboxamides.
Dolezal M; Cmedlova P; Palek L; Vinsova J; Kunes J; Buchta V; Jampilek J; Kralova K
Eur J Med Chem; 2008 May; 43(5):1105-13. PubMed ID: 17870211
[TBL] [Abstract][Full Text] [Related]
11. Novel pyrazine based anti-tubercular agents: Design, synthesis, biological evaluation and in silico studies.
Hassan NW; Saudi MN; Abdel-Ghany YS; Ismail A; Elzahhar PA; Sriram D; Nassra R; Abdel-Aziz MM; El-Hawash SA
Bioorg Chem; 2020 Mar; 96():103610. PubMed ID: 32028062
[TBL] [Abstract][Full Text] [Related]
12. Alkylamino derivatives of pyrazinamide: synthesis and antimycobacterial evaluation.
Servusová B; Paterová P; Mandíková J; Kubíček V; Kučera R; Kuneš J; Doležal M; Zitko J
Bioorg Med Chem Lett; 2014 Jan; 24(2):450-3. PubMed ID: 24388809
[TBL] [Abstract][Full Text] [Related]
13. Derivatives of 3-Aminopyrazine-2-carboxamides: Synthesis, Antimicrobial Evaluation, and in Vitro Cytotoxicity.
Bouz G; Semelková L; Janďourek O; Konečná K; Paterová P; Navrátilová L; Kubíček V; Kuneš J; Doležal M; Zitko J
Molecules; 2019 Mar; 24(7):. PubMed ID: 30925695
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, antimycobacterial and antifungal evaluation of some new 1-ethyl-5-(hetero)aryl-6-styryl-1,6-dihydropyrazine-2,3-dicarbonitriles.
Verbitskiy EV; Slepukhin PA; Kravchenko MA; Skornyakov SN; Evstigneeva NP; Kungurov NV; Zil'berberg NV; Rusinov GL; Chupakhin ON; Charushin VN
Bioorg Med Chem Lett; 2015 Feb; 25(3):524-8. PubMed ID: 25556103
[TBL] [Abstract][Full Text] [Related]
15. Development of selective DprE1 inhibitors: Design, synthesis, crystal structure and antitubercular activity of benzothiazolylpyrimidine-5-carboxamides.
Chikhale R; Menghani S; Babu R; Bansode R; Bhargavi G; Karodia N; Rajasekharan MV; Paradkar A; Khedekar P
Eur J Med Chem; 2015; 96():30-46. PubMed ID: 25874329
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and antimycobacterial activities of some new thiazolylhydrazone derivatives.
Ozadali K; Tan OU; Yogeeswari P; Dharmarajan S; Balkan A
Bioorg Med Chem Lett; 2014 Apr; 24(7):1695-7. PubMed ID: 24631185
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and evaluation of covalent inhibitors of DprE1 as antitubercular agents.
Liu L; Kong C; Fumagalli M; Savková K; Xu Y; Huszár S; Sammartino JC; Fan D; Chiarelli LR; Mikušová K; Sun Z; Qiao C
Eur J Med Chem; 2020 Dec; 208():112773. PubMed ID: 32898793
[TBL] [Abstract][Full Text] [Related]
18. Salicylanilide pyrazinoates inhibit in vitro multidrug-resistant Mycobacterium tuberculosis strains, atypical mycobacteria and isocitrate lyase.
Krátký M; Vinšová J; Novotná E; Stolaříková J
Eur J Pharm Sci; 2014 Mar; 53():1-9. PubMed ID: 24333643
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and antimycobacterial properties of N-substituted 6-amino-5-cyanopyrazine-2-carboxamides.
Zitko J; Dolezal M; Svobodova M; Vejsova M; Kunes J; Kucera R; Jilek P
Bioorg Med Chem; 2011 Feb; 19(4):1471-6. PubMed ID: 21273083
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and Biological Evaluation of N-Alkyl-3-(alkylamino)-pyrazine-2-carboxamides.
Semelkova L; Konecna K; Paterova P; Kubicek V; Kunes J; Novakova L; Marek J; Naesens L; Pesko M; Kralova K; Dolezal M; Zitko J
Molecules; 2015 May; 20(5):8687-711. PubMed ID: 26007174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]